Di Nuzzo Private Wealth, Inc. Ironwood Pharmaceuticals Inc Transaction History
Di Nuzzo Private Wealth, Inc.
- $577 Million
- Q1 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 18 shares of IRWD stock, worth $116. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18
Previous 17
5.88%
Holding current value
$116
Previous $195,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IRWD
# of Institutions
296Shares Held
170MCall Options Held
27.1MPut Options Held
2.28M-
Black Rock Inc. New York, NY24.2MShares$157 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$127 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$106 Million24.97% of portfolio
-
State Street Corp Boston, MA13.9MShares$90.3 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA7.21MShares$46.8 Million0.16% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $994M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...